MEXICO: President Trump is expected to nominate Heidi Overton to lead the Food and Drug Administration. Overton is currently the deputy director of the White House Domestic Policy Council and is a prominent conservative policy aide. She has played a significant role in shaping health policies during Trump's second term. Overton has a strong academic background, holding a medical degree from the University of New Mexico School of Medicine and a doctoral degree in clinical investigation from Johns Hopkins Bloomberg School of Public Health.
Her nomination comes after the ousting of the previous FDA commissioner, Marty Makary, amid various controversies. Overton's nomination has drawn mixed reactions, particularly from the Make America Healthy Again movement, which has been critical of some of her policy positions. The nomination of Overton could signal a shift in FDA policy direction, impacting future regulatory approaches. The confirmation process will be closely watched, as it could influence the administration's health policy agenda moving forward.
Image credit: ARS TECHNICA
